Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Eric Rowinsky
AddedMar 31, 2024
UpdatedMay 31, 2026
Eric Rowinsky

Eric Rowinsky

Board Member, Fortress Biotech

CrunchbaseLinkedIn

Eric Rowinsky's Career

Fortress Biotech
Fortress Biotech

New York City, NY, US

Board Member· Board
Verastem
Verastem

Needham, MA, US

Board Member· Board
Biogen
Biogen

Cambridge, MA, US

Board Member· Board
Primrose Therapeutics
Primrose Therapeutics

New York City, NY, US

Founder
Inspirna
Inspirna

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Eric Rowinsky's Career

Fortress Biotech
Fortress Biotech
Public$196.8M1872006New York City, NY, US
Board Member· Board

Leadership at Fortress Biotech

Lindsay RosenwaldLindsay RosenwaldBoard Member
Lindsay RosenwaldLindsay RosenwaldFounder & CEO
Michael S WeissMichael S WeissBoard Member
Neil HerskowitzNeil HerskowitzBoard Member
Dr Jeffrey Paley \"Jeff\"Dr Jeffrey Paley \"Jeff\"Board Member

Similar to Fortress Biotech

Journey MedicalJourney MedicalScottsdale, AZ, USDermatology Productsest. 2014Journey MedicalScottsdale, AZ, US · est. 2014

Journey Medical Corp, a Fortress Biotech subsidiary, provides branded dermatology products.

Public · $39M89
Dermavant SciencesDermavant SciencesLong Beach, CA, USDermatology, Therapeuticsest. 2016Dermavant SciencesLong Beach, CA, US · est. 2016

Dermavant Sciences: A clinical-stage biopharmaceutical firm specializing in dermatology solutions.

Public · $160M338
Arcutis BiotherapeuticsArcutis BiotherapeuticsWestlake Village, CA, USBiopharmaceuticalsest. 2016Arcutis BiotherapeuticsWestlake Village, CA, US · est. 2016

Founded in 2016, Arcutis is a clinical-stage biopharmaceutical company innovating in medical dermatology.

Public · $683.5M268
DermBiontDermBiontBoston, MA, USTherapeuticsest. 2017DermBiontBoston, MA, US · est. 2017

DermBiont: A leading precision dermatology firm, developing targeted therapeutics for skin health.

Series B · $108.5M47
Verastem
Verastem
Public$280M1002010Needham, MA, US
Board Member· Board

Leadership at Verastem

Brian StuglikBrian StuglikBoard Member
John H. JohnsonJohn H. JohnsonBoard Member
Michelle DippMichelle DippFounder
Robert WeinbergRobert WeinbergBoard Member
Michael KauffmanMichael KauffmanBoard Member
Stephen KrausStephen KrausBoard Member
Biogen
Biogen
Public$1.5B8.7k1978Cambridge, MA, US
Board Member· Board

Leadership at Biogen

Walter GilbertWalter GilbertCo-Founder
Christopher ViehbacherChristopher ViehbacherCEO
Kasper LageKasper LageBoard Member
Phillip SharpPhillip SharpCo-Founder
Bill HawkinsBill HawkinsBoard Member
Stelios PapadopoulosStelios PapadopoulosBoard Member

Similar to Biogen

Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
GenentechGenentechSouth San Francisco, CA, USBiopharmaceuticalsest. 1976GenentechSouth San Francisco, CA, US · est. 1976

Genentech, Inc.: A pioneering US biotech firm, operating as an independent subsidiary of Roche.

Public13.5k
bluebird biobluebird bioCambridge, MA, USGene Therapiesest. 1992bluebird bioCambridge, MA, US · est. 1992

Bluebird Bio, Inc.: A US-based biotech firm offering gene therapies for severe genetic disorders.

Public · $3.4B323
Gilead SciencesGilead SciencesFoster City, CA, USPharmaceuticals, Therapiesest. 1987Gilead SciencesFoster City, CA, US · est. 1987

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

Public · $2B17k
Primrose Therapeutics
Primrose Therapeutics
Seed$752.5k52010New York City, NY, US
Founder

Leadership at Primrose Therapeutics

Zachary S. SharonZachary S. SharonCEO
Inspirna
Inspirna
Series D$144.6M312010New York City, NY, US
Board Member· Board

Leadership at Inspirna

Usman AzamUsman AzamCEO
Sohail TavazoieSohail TavazoieCo-Founder
Jack NielsenJack NielsenBoard Member
Antoine PapiernikAntoine PapiernikBoard Member
Shahram Seyedin-NoorShahram Seyedin-NoorCo-Founder
Masoud TavazoieMasoud TavazoieCo-Founder

Eric Rowinsky's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Eric Rowinsky

Ivan VeraIvan VeraFounder · MagicalMichael WangMichael WangCo-Founder · InspirenAnn PayneAnn PayneBoard Member · InspiratoByron AlsbergByron AlsbergCo-Founder · Prefix CapitalJohn RiceJohn RiceCo-Founder · Triathlon Medical Venture Partners